medigraphic.com
Instituto Nacional de Salud Pública

2003, Number 4

<< Back Next >>

salud publica mex 2003; 45 (4)

Out-of-pocket expenditures during hospitalization of young leukemia patients with state medical insurance in two Mexican hospitals

Rocha-García A, Hernández-Peña P, Ruiz-Velazco S, Avila-Burgos L, Marín-Palomares T, Lazcano-Ponce E

Language: Spanish
References: 20
Page: 285-292
PDF size: 107.14 Kb.


ABSTRACT

Objective. To estimate out-of-pocket expenditures for health care during the first hospitalization of children treated for leukemia in two hospitals of the Mexican Institute of Social Security (Instituto Mexicano del Seguro Social–IMSS–). Material and Methods. A cross-sectional study was conducted in Mexico City and Leon, Guanajato, Mexico in 1997. The study population consisted of the parents of 51 children under 15 years of age diagnosed with leukemia, who were hospitalized for the first time in two IMSS hospitals. A questionnaire was applied to participants to obtain direct and indirect expenditures during that period. Consumer price indexes (1997-2002) were used to estimate expenditure prices for 2002. Average expenditures and catastrophic expenditures were estimated. Factors associated with expenditures were analyzed using a linear regression model in which the dependent variable was the total household expenditures during hospitalization. Results. The average household cost per hospitalization was 7 318 pesos, 86% of which corresponded to medical care and 14% to indirect costs. Catastrophic expenditures occurred in 14% of households. In 47% of household expenditures exceeded 100% of the total household income during the hospitalization period. Expenditures during hospitalization were associated with place of residence, income level, and type of medical insurance. Conclusions. Being an IMSS policyholder decreased out-of-pocket expenditures, but not complementary expenditures, which may still be unaffordable for a large segment of the population. For more than a half of the households studied, continuity of care was compromised, as expenditures during the first hospitalization entailed using up savings, going into debt, and/or selling household property.


REFERENCES

  1. Van Roijen L, Koopmanschap M, Rutten F, Van der M. Indirect cost of diseases: An international comparison. Health Policy 1995;33:15-29.

  2. Gold M, Siegel J, Russell L, Weinstein M. Cost-effectiveness in health and medicine. Massachusetts (MA): Oxford University Press, 1996.

  3. Avila L, Gutiérrez C, Hernández P, Santos C, Silva L. EL costo social de la bronquitis crónica en la Ciudad de México: una experiencia piloto. Salud Publica Mex 1996;30(2):128-138.

  4. Drummond M, Stoddart G, Torrance G. Métodos para la evaluación económica de los programas de atención a la salud. Madrid: Ed. Díaz de Santos, 1991.

  5. Instituto Mexicano del Seguro Social. Ley del Instituto Mexicano del Seguro Social. México, DF: IMSS, 1998.

  6. Instituto Mexicano del Seguro Social. Hacia el fortalecimiento y modernización de la seguridad social. México, DF: IMSS, 1996.

  7. Secretaría de Salud. Programa Nacional de Salud 2001-2006. México, DF: SSA, 2001.

  8. Secretaría de Salud. Encuesta Nacional de Salud II. México, DF: SSA,1994.

  9. Murray CJL, Knaul F, Musgrove P, Xu K, Kawabata K. Defining and measuring fairness in financial contribution to the health system. GPE. Ginebra: WHO, 2001; Discussion Paper Series. No. 24. WHO.2001.Disponible en http://www3.who.int./whosis/ discussion_papers/pdf/paper24.pdf

  10. Rivera-Luna R. Primer consenso de leucemia aguda linfoblástica pediátrica en México. Rev Invest Clin 1997;49:309-316.

  11. Banco de México. Indicadores de precios. Tasa de inflación series 1997-2001. México, DF: Banco de México, 2002. Disponible en: http:ww.banxico.org.mx

  12. Varian H. Microeconomía intermedia: un enfoque actual. 4ª edición. España: Antoni Bosh, ed, 1996:163-202.

  13. Grene W. Econometrics analysis. Fourth Edition. Nueva York (NY): Prentice Hall,2000: 258.

  14. Berrino F, Esteve J, Coleman MP. Basic issues in estimating and comparing the survival of cancer patients. Lyon: IARC Scientific Publications, 1995:1-14.

  15. Poullier JP, Hernández P, Kawabata K. Nacional health accounts: Sources, data and methods. Ginebra: WHO, 2002; Discussion Paper 47. WHO, 2002. Disponible En: http://www3.who.int./whosis/discussion_papers/pdf/paper47.pdf

  16. Yepes LFJ. Gasto privado en salud. Colombia 1977-1980. Gac Med Mex 1984;15(2):49-54.

  17. Musgrove P. Family health care spending in Latin America. J Health Econ 1983;2:245-257.

  18. Instituto Nacional de Estadística, Geografía e Informática. Encuesta Nacional de Ingresos y Gasto de los Hogares (ENIGH). México DF: INEGI, 1996.

  19. Lobato-Mendizábal E, Ruiz-Argüéllez G, Marín-López A. Leukemia ad nutrition. Malnutrition is an adverse prognostic factor in the outcome of treatment of patients with standard-risk acute lymphoblastic leukemia. Leuk Res 1989;13(10):899-906.

  20. MISSOC. Social protection in the EU Member States and the European Economic Area. Luxemburgo: European Commission, 2000.




2020     |     www.medigraphic.com